Evidence map›Paper›PMID 41262639›Full record

ReviewArchivos peruanos de cardiologia y cirugia cardiovascular

Recommendations for the management of ST-elevation myocardial infarction after reperfusion.

Frank W Britto

Abstract readReview
In one paragraph

Review in Archivos peruanos de cardiologia y cirugia cardiovascular. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Betabloqueadores en pacientes posinfarto de miocardio.Archivos peruanos de cardiologia y cirugia cardiovascular
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Frank W BrittoServicio de Cardiología Clínica, Instituto Nacional Cardiovascular - INCOR, EsSalud. Lima, Peru. Servicio de Cardiología Clínica Instituto Nacional Cardiovascular - INCOR, EsSalud Lima Peru.ORCID https://orcid.org/0009-0004-2191-4829

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The management of ST-segment elevation myocardial infarction (STEMI) after reperfusion requires critical decision-making in patients with multivessel disease (MVD), acute heart failure, and left ventricular (LV) thrombus. Complete revascularisation of non-culprit lesions ≥70% is recommended either during the index procedure or within the first 19 days, particularly in haemodynamically stable patients. Coronary artery bypass grafting is indicated for high-risk anatomy or complex lesions following successful percutaneous coronary intervention, where a hybrid approach may combine percutaneous intervention with surgery, and timing should be adjusted according to whether a stent was implanted. Post-infarction heart failure, which occurs in 28-31% of cases, requires urgent management; continuous monitoring and timely intervention can reduce complications. In patients with cardiogenic shock or mechanical complications, intra-aortic balloon pump support and inotropes may be necessary. Right ventricular infarction is managed with volume resuscitation, urgent revascularisation, and, when required, pharmacological support or pacing. LV thrombus, more frequent after anterior infarction with LVEF <50%, mandates early detection by echocardiography and/or tomography, and prompt anticoagulation, preferably with warfarin, with triple therapy considered in patients at high thrombotic risk. This manuscript outlines recommendations to optimise prognosis through early, evidence-based, and individualised interventions.

Indexed as

Acute Coronary SyndromesHeart FailureMyocardial InfarctionMyocardial Revascularization

Identifiers

PMID41262639
PMCPMC12624448

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.